G-nib 250 mg Tablet
30,60$
23,87$
G-nib 250 mg Tablet is an effective treatment option for adults diagnosed with advanced non-small cell lung cancer (NSCLC) characterized by mutations in the EGFR gene, particularly in cases where the cancer has metastasized to other areas of the body. This targeted therapy works by inhibiting the growth of cancer cells that rely on the abnormal EGFR signaling for survival and proliferation, thus slowing down disease progression. However, it is important to note that G-nib 250 mg is not approved for use in children or adolescents due to insufficient data regarding its safety and efficacy in these populations. Patients should be aware of potential side effects, which may include gastrointestinal issues and skin reactions, and should consult their healthcare provider about any concerns. Regular monitoring by a healthcare professional is essential to manage any adverse effects effectively. As with any cancer treatment, it is crucial to follow the prescribed dosage and treatment regimen for optimal results. G-nib 250 mg Tablet represents a significant advancement in the personalized approach to treating NSCLC, offering hope for patients navigating this challenging diagnosis. Always discuss with your doctor to understand if G-nib is the right choice for your treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• G nib 250 mg tablet is primarily used in the treatment of non-small cell lung cancer (NSCLC). This specific type of lung cancer affects a large portion of lung cells, making it a common diagnosis. The medication works by targeting specific pathways involved in cancer cell growth. By inhibiting these pathways, G nib 250 mg tablet helps slow down the progression of the disease.
• In patients diagnosed with advanced non-small cell lung cancer, G nib 250 mg tablet may be prescribed to improve overall survival rates. Its targeted action allows for a more effective approach to managing the disease. This treatment option is particularly beneficial for individuals who may not respond to traditional therapies. G nib 250 mg tablet plays a crucial role in the comprehensive management of NSCLC.
• G nib 250 mg tablet is often utilized in combination with other therapeutic agents for enhanced efficacy. This multi-faceted approach can optimize treatment outcomes for patients with non-small cell lung cancer. The medication's ability to work synergistically with other drugs makes it a valuable addition to cancer care. Healthcare providers frequently recommend G nib 250 mg tablet as part of a tailored treatment plan.
• Patients receiving G nib 250 mg tablet may experience a better quality of life during their cancer treatment journey. By effectively targeting the cancer cells, this medication can help alleviate some of the symptoms associated with non-small cell lung cancer. The focus on improving patient outcomes is a key aspect of using G nib 250 mg tablet. It aims to support individuals in managing their condition more effectively.
Benefits
G-nib Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, G-nib 250 Tablet may help to slow the progression of cancer.
G-nib 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
G-nib Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, G-nib 250 mg Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection

